During the past decade, Schwerpunktpraxis Diabetes conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Schwerpunktpraxis Diabetes" are "Type 1 Diabetes Mellitus" (1 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Schwerpunktpraxis Diabetes" in a lesser frequency.

Most popular intervention types in "Schwerpunktpraxis Diabetes" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Tirzepatide" (2 trials), "Dulaglutide" (1 trials), "Insulin Lispro" (1 trials), "Placebo" (1 trials) and "Ultra-Rapid Lispro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwerpunktpraxis Diabetes" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Schwerpunktpraxis Diabetes". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Schwerpunktpraxis Diabetes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schwerpunktpraxis Diabetes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".